| Date |
Report No. |
Title |
| Date Dec. 15, 1994 |
Report No. HEHS-95-34R |
Title
GAO United States General Accounting Office Washington, D.C. 20648 Health, Education and Human Services Division B-232863 December 15, 1994 The Honorable Tim Valentine, Chairman The Honorable Tom Lewis, Ranking Minority Member The Honorable Peter I. Blute Subcommittee on Technology, Environment and Aviation Committee on Science, Space, and Technology House of Representatives Members of Congress ha... |
| Date Dec. 6, 1994 |
Report No. GGD-95-29FS |
Title
United States General Accounting Office GAO
December 1994 Fact Sheet for the Chairman, Committee on Post Office and Civil Service House of Representatives U.S. POSTAL SERVICE Drug Investigation Data GAO/GGD-95-29FS GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-259292 December 6, 1994 The Honorable William L. Clay Chairman, Committee on Post Office... |
| Date Aug. 12, 1994 |
Report No. HEHS-94-200R |
Title
United States General Accounting Offlce WashIngton, D.C. 20548 Health, Education and Human Services Divlslon rn3y/- B-226377 August 12, 1994 The Honorable Henry A. Waxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce House of Representatives Dear Mr. Chairman: As the debate over U.S. health care reform continues, prescription drug prices remain the subject o... |
| Date Aug. 5, 1994 |
Report No. AIMD-94-130 |
Title
United States General Accounting Office GAO
August 1994 Report to the Chairman, Committee on the District of Columbia, House of Representatives PRESCRIPTION I DRUGS Automated Prospective Review Systems Offer Potential Benefits for Medicaid GAOIAIMD-94-130 United St&es General Accounting Office Washington, D.C. 20648 Accounting and Information Management Division B-257257 August 5, 1994 The Honorab... |
| Date Aug. 5, 1994 |
Report No. HEHS-94-194FS |
Title
GAO
August 1994 United States General Accounting Office /LJ?Fz24- Fact Sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives MEDICAID Chmges in Best Price for Outpatient Drugs Purchased by HMOs and Hospitals GAO/EEHS-94-194FS 1 Notice: This is a reprint of a GAO r&d United States General Accounting Office W... |
| Date Aug. 1, 1994 |
Report No. HEHS-94-207R |
Title
GAO United States GeneraI Accounting Office Washington, D.C. 20548
Human Resources Division B-257891 August 1, 1994 The Honorable Jimmy Hayes House of Representatives Dear Mr. Hayes: Most patients who receive organ transplants take immunosuppressant drugs to lower the chance that their bodies will reject the transplanted organs. These drugs are quite expensive-- costing from $4,000 to $6,000 per p... |
| Date July 27, 1994 |
Report No. T-HEHS-94-213 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 930 a.m., EST Wednesday July 27, 1994 Testimony
Before the Committee on Governmental Affairs United States Senate PRESCRIPTION DRUGS Prices and Regulation in Canada and Europe
Statement of Sarah F. Jaggar Director, Health Financing and Policy Issues Health, Education, and Human Services Division Messrs. Chairmen and Me... |
| Date July 22, 1994 |
Report No. PEMD-94-26 |
Title
,..
,” . : , ‘. , . I GAO United States General Accounting Office Washiin, D.C. 20648 Program Evaluation and Methodology Division
B-253555 July 221994 The Honorable Edolphus Towns Chairman, Human Resources and Intergovernmental Relations Subcommittee Committee on Government Operations House of Representatives Dear Mr. Chairman: In October 1992, the Congress passed the Prescription Drug User Fe... |
| Date May 17, 1994 |
Report No. HEHS-94-30 |
Title
Health, Education, and Human Services Division B-251111 May 17,1994 The Honorable David H. Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: This report, prepared at your request, examines how other countries regulate prescription drug prices, how those policies affect drug prices, and how they affect pharmaceutical research and development. As arranged with your ... |
| Date May 6, 1994 |
Report No. HEHS-94-136R |
Title
w-8 Y GAO Washington,D.C.20548
Human Resources Division United States General Accounting Office 1 B-256121 May 6, 1994 The Honorable John D. Dingell Chairman, Committee on Energy House of Representatives The Honorable United States Orrin G. Hatch Senate and Commerce Because of changes over the last few years in the Food and Drug Administration's (FDA) monitoring of generic drug manufacturers,l you... |
| Date Jan. 12, 1994 |
Report No. HEHS-94-29 |
Title
United States General Accounting Office GAO
January 1994 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives ’ PRESCRIPTION DRUGS Companies Qpically Charge More in the United States Than in the United Kingdom GAO United States General Accounting Office Washington, D.C. 20648 Human Health, Education, and Services Division ... |
| Date Nov. 15, 1993 |
Report No. T-GGD-94-49 |
Title
United StatesGeneralAccounting Offwze GAO
For Releaseon Delivery Expectedat November 15, 1993 2:OO p.m. Testimony
Before the Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations House of Representatives DRUG CONTROL The Offke of National Drug Control Policy-Strategies u Need PerformanceMeasures
Statement of Henry R. Wray Director Administration of Justice Is... |
| Date Oct. 13, 1993 |
Report No. HRD-94-1R |
Title
.GAO United states General Acconnting OfIke Wwhtngton, D.C. 20648 Human Resources Division B-250909 October 13, 1993 The Honorable Fortney H, (Pete) Stark Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives Dear Mr. Chairman:
This letter responds to your request that.we evaluate the methodology and data used by the Health Care Financfng Administration (HCFA) to es... |
| Date Oct. 5, 1993 |
Report No. T-PEMD-94-4 |
Title
United States General Accounting Oflice GAO
For Release on Delivery Expected at IO:00 a.m., EDT Tuesday, October 5, 1993 Testimony
Before the Subcommittee on Legislation and National Security, Committee on Government Operations, House of Representatives 1 DRUG USE MEASUREMENT Strengths,Limitations, and Recommendations for Improvement
Statement of Frederick Mulhauser, Assistant Director, Program Ev... |
| Date Aug. 2, 1993 |
Report No. HRD-93-118 |
Title
GAO
August 1993 Report to Congressional Requesters MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-246968 August 2,1993 The Honorable Charles Range1 House of Representatives The Honorable Edolphus Towns Chairman, Subcommittee on Human Resources and Intergovernmental Relatio... |
| Date Aug. 2, 1993 |
Report No. T-HRD-93-28 |
Title
United States General Accounting Office 14qG61 - - * Testimony
Before the Subcommitteeon Human Resourcesand IntergovernmentalRelations, Committee on GovernmentOperations House of Representatives
For Releaseon Delivery Expected at 9:30 a.m. Monday August 2,1993 MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities
Statementof Leslie G. Aronovitz AssociateDirector, Health F... |
| Date April 12, 1993 |
Report No. HRD-93-81 |
Title
IJnited States General Accounting Office Report to Congressional Requesters FDA PREMARKET APPROVAL Process of Approving Lodine as a Drug GAO United States General Accounting Of’ flce Washington, D.C. 20548 Human Resource6 Division B-262669 April 12,1903 The Honorable William J. Hughes Chairman, Subcommittee on Intellectual Property and Judicial Administration Committee on the Judiciary House of ... |
| Date March 18, 1993 |
Report No. HRD-93-55FS |
Title
-I nl;krTll I !Wl MEDICAID Outpatient Drug Costs and Reimbursements for Selected Pharmacies in Illinois and Maryland 14864’ 3 \.. ~- ’ (;Ao/llItI)-!):3-5f,I1’ S - __---___-- - GAO United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-251918 March 18, 1993 The Honorable Daniel P. Moynihan, Chairman The Honorable Bob Packwood, Ranking Minority Member Committ... |
| Date Feb. 22, 1993 |
Report No. T-HRD-93-5 |
Title
United StatesGenerd kmmtinp Office GAO
For Release D&very on Eqwedat 1050 am., EST
Mai&ly Testimony
Before the Subcommitteeon Health and the Environment; Committee on Energy and Commerce, _ House of Representatives PRESCRIPTIONDRUGS CompaniesTypically Charge More in the United States Than in Canada
Statementof Janet L. SWes, Director, Health Financing and Policy Issues, Human ResourcesDivision Fcb... |
| Date Feb. 17, 1993 |
Report No. HRD-93-51 |
Title
PRESCRIPTION DRUG PRICES i 48527 Ill RESTRICTED-Not to be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. I 5Sb’ f58 RELEASED GAO United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-247942 February 17, 1993 The Honorable David Pryor Chairman, Special Committee on Aging United States Senate... |
| Date Jan. 28, 1993 |
Report No. NSIAD-93-104 |
Title
----- .J;IIIII;~~~ I!)93 DRUG CONTROL Status Report on Counterdrug Technology Development 148486 RESTRICTED--Not to be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 6,563(// RELEASED GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-242664 January 28, 1993... |
| Date Jan. 15, 1993 |
Report No. HRD-93-43 |
Title
MEDICAID Changes in Drug Prices Paid by HMOs and Hospitals Since Enactment of Rebate Provisions .,, --. Y
148334 GAO United States General Accounting OMce Washington, D.C. 20548 Human Resources Division B-245873 January 15, 1993 The Honorable Lloyd Bentsen, Chairman The Honorable Bob Packwood, Ranking Minority Member Committee on Finance United States Senate The Honorable John D. Dingell, Chairman... |
| Date Oct. 29, 1992 |
Report No. HRD-93-17 |
Title
IJnited States General Accounting Office Report to Congressional Requesters Octobt?r 1992 WOMEN’ HEALTH S FDA Needs to Ensure More Study of Gender Differences~ in Prescription Drug Testing, II II
147861 GAO/HRD-93-1’ 7 . United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-243898 October 29,1992 The Honorable Henry A. Waxman Chairman, Subcommittee on Health... |
| Date Sept. 30, 1992 |
Report No. HRD-92-110 |
Title
c
lJnited States General Accounting Office GAO
September 1992 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce; House of Representatives PRESCRIPTION DRUGS Companies Q-pieally Charge More in the United States Than in Canada
,- aESTRICTED--Not to be released outside the General Accounting Offke unless specifically approved by the Office of Congres... |
| Date Aug. 31, 1992 |
Report No. RCED-92-231 |
Title
All~llst. awz CANCER TREATMENT Actions Taken to More Fully Utilize the ESark of Pacific Yews on Federal Land RESTI&ICTEIX-Not to be ?eleas&l~outside ‘the General Accounting Office unless specifically approved by the Offke of Congressional Relations., ” ..-- -.. ._-. I.-...~..I*.. --.-..I..--...-.----_ ..” . . -_-_-_--I -. i m GAO United Statee General Accounting OffIce Washington, D.C. 20648... |
| Date Aug. 24, 1992 |
Report No. HRD-92-128 |
Title
GAO PRl%%?RIPTION DRUGS Changes in Prices for Selected Drugs 147429 RES’rRICTED-Not to. be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 555141, RELEM GAO United States General Accounting Oftlce Washingtan, D.C. 20648 Human Resources Division B-249610 August 24, 1992 The Honorable Byron L. Dorgan House of Representatives The... |
| Date Aug. 5, 1992 |
Report No. RCED-92-209 |
Title
FOOD SAFETY AND QUALITY FDA Strategy Needed to Address Animal Drug Residues in Milk
,-. II lllllM Ill
147221 .._ b . .__ .__. --..ll.-- ._--. .._. I” .-I_--. ----~.- (;Ao,IRCEI)-92-209 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Division B-246269 August 5,1992 The Honorable Ted Weiss Chairman, Human Resourcesand Intergovernmen... |
| Date Aug. 5, 1992 |
Report No. T-RCED-92-89 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday August 5, 1992 Testimony
Before the Human Resources and Intergovernmental Relations Subcommittee Committee on Government Operations House of Representatives FOOD SAFETY AND QUALITY FDA Strategy Needed Address Animal Drun Residues in Milk
Statement of John W. Harman, Director, Food and Agricultu... |
| Date July 29, 1992 |
Report No. T-HRD-92-48 |
Title
United States (ieneral Accounting Office
1 Testimony
Before the Select Committee on Narcotics Abuse and Control. House of Representatives For Release: Delivery on Expectedat IO:(W) a.m. Wtxlnt!sday July 29. 1992 MEDICAID PRESCRIPTION DRUG DIVERSION A Major Problem, But State Approaches Offer Some Promise
Statement of Janet L. Shikles, Director Health Financing and Policy Issues Human Resources Div... |
| Date July 21, 1992 |
Report No. HRD-92-115 |
Title
‘ ‘ V r IJrritttd Stittes General Accounting Office ---- - -.- _- -..-~-~.~~ Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives .uly l!fW PRESCRIPTION MONITORING DRUG States Can Readily Identify Illegal Sales and Use of Controlled Substances .
/
147189 ,- IlllllllRlllll ” . RESTRICTED--Not to be releaped outside the General Accounting Office... |
| Date May 27, 1992 |
Report No. GGD-92-95FS |
Title
Fact Sheet for the Chairman and Ranking Minority Member, Committee on Government Operations, House of Representatives
Muy 1992 WAR ON DRUGS Heroin Price, Purity, and Quantities Seized Over the Past 10 Years IllllllllllIl ll
147113 RESTRICTED-Not to be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 55q54s- RELEASED GAO/GGI)-92-9... |
| Date April 28, 1992 |
Report No. T-PEMD-92-8 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at IO:00 am., EDT Tuesday, April 28, 1992 Testimony
Before the Subcommittee on Regulation, Business Opportunities and Energy Committee on Small Business House of Representatives OVER THE COUNTER DRUGS Gaps and Potential Vulnerabilities in the Regulatory System
Statement of Kwai-Cheung Chan Director of Program Evaluation i... |
| Date April 8, 1992 |
Report No. T-PEMD-92-5 |
Title
Uniied States General Accounting Office GAO
For releaseon Delivery Expected at IO:00 a.m., EDT Wednesday, April 8, 1992 Testimony
Before the Subcommitteeon Human Resources and Intergovernmental Relations Committee on Government Operations House of Representatives NONPRESCRIPTION DRUGS Over the Counter and Underemphasized
Statementof Kwai-Cheung Chan Director of Program EvaIuation in Physical Syste... |
| Date April 7, 1992 |
Report No. HRD-92-85 |
Title
GAO United States General Accounting OflIce Washington, D.C. 20648 Human Resources Division B-248171 April 7,1992 The Honorable William J. Hughes Chairman, Subcommittee on Intellectual Property and Judicial Administration Committee on the Judiciary House of Representatives The Honorable Dennis DeConcini Chairman, Subcommittee on Patents, Copyrights, and Trademarks Committee on the Judiciary Unite... |
| Date March 13, 1992 |
Report No. T-HRD-92-16 |
Title
United States General Accounting Offke GAO
FatRelease Delivery on Expected at 9:30 am., EST Friday, March13.1992 Testimony
Before the Subcommitteeon Health and Long-Term Care, Select Committee on Aging, House of Representatives BOARDANDC~ HOMES Medication Mishandling Places Elderly at Risk
Statementof JosephF. Delfico Director, Income Security Issues Human ResourcesDivision GAO/T-HRD-92-16 GAO For... |
| Date March 4, 1992 |
Report No. T-RCED-92-36 |
Title
United StatesGeneral Accounting Of&e Testimony
Before the Sub. on Fisheriesand Wildlife Conservationand the Environment, Corn. on Merchant Marine and Fisheries;the Sub. on National Parks and Public Lands, Corn. on Interior and Insular Affairs; and the Sub. on Forests,Family Farmsand Energy, Corn. on Agriculture, House of Representatives
For Release on Delivery Expected at IO:00 a.m., EST Wednesday... |
| Date Feb. 7, 1992 |
Report No. HRD-92-45 |
Title
-.._, ,. . ._. _- _-._ I.-I” _.-_. -. I .__.__-___. -_.-. 1 !)!I2 .- _._ -... ---..- ..__.._ .____._......_ --- __..._ l_-__--“. ________ ~___- .__. ---- It’ (~t)IWiWV BOARD AND CARE HOMES Elderly at Risk From Mishandled Medications i lllllllllllllIll
146111 RESTRICTED--Not to be released &&@@~~ General Accounting Office unless specifica y approved by the Office of Congressional Relations. (... |
| Date Jan. 22, 1992 |
Report No. HRD-92-30 |
Title
GAO
*JlltlllllI-y I!)!):! _-- VA HEALTH CXRE Modernizing VA’ s Mail-Service Pharmacies Should Save Millions of Dollars II I
145672 GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-247064 January 22, 1992 The Honorable F’ rank H. Murkowski United States Senate Dear Senator Murkowski: Mail-service pharmacies are playing an increasing role in slowing t... |
| Date Jan. 10, 1992 |
Report No. PEMD-92-9 |
Title
rlltllm-y 199% NONPRESCRIPTION DRUGS Over the Counter and Underemphasized GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-246187 January lo,1992 The Honorable Ron Wyden Chairman, Subcommittee on Regulation, Business Opportunities, and Energy Committee on Small Business House of Representatives Dear Mr. Chairman: In your letter of Feb... |
| Date Aug. 12, 1991 |
Report No. 144675 |
Title
United States General .- Accounting Office GAO
-- Office of Counseling and Career Development /YL/r$7?r Tips on Managing Stress -___” --.----___ _~ _,__ I _____._ _._I.II.. - _.-,___ .-... __... ---.l----_- I..-..- ““... .” .- -.. --~ -11---- ._------ -.-.. -l-.-l--l-. TIPS ON MANAGINGSTRESS
Contents
BASIC CONCEPTS
OPT FOR OPTIMISM.. . , . , . . . , , . . . . . . . m . . . a. . . . . . . .... |
| Date July 22, 1991 |
Report No. PEMD-91-20 |
Title
.Jx~l\, I!)!)1 1 PRESCRIPTION DRUGS Selected Direet-toConsumer Advertising Studies Have Methodological Flaws --. -- . 2 ,,, . . .\ -.-- (;AO/I’ I~MI)-!jl-20 GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-243615
July 22,199l The Honorable John D. Dingell Chairman, Subcommittee on Oversight and Investigations Committee on Energy and... |
| Date July 9, 1991 |
Report No. PEMD-91-19 |
Title
3 c3 cI ^.i _.__. . I^ ._... i^. ._._ . ..- _ ...__I.. .-~..- . ..-._._ - ..--. -_- ._.---...... ..-...-.. ’ GAO Gemeral Accounting OffIce WaUngton, D.C. 20648 Program Evaluation aud Methodology Division unit.4ld states I B-243616 July 9,lQQl The Honorable John D. Dingell Chairman, Subcommitteeon Oversight and Investigations Committee on Energy and Commerce House of Representatives Dear Mr. Chai... |
| Date April 3, 1991 |
Report No. GGD-91-56BR |
Title
m.-- April 1 !)!)I DRUG CONTROL Implementation of the Chemical Diversion and Trafficking Act of 1988 linked States General Accounting Of?ke Washington, D.C. 20.540 General Government Division l B-243007
April 3,199l The Honorable United States Dear Senator Edward M. Kennedy Senate Kennedy: This briefing report responds to your request for information on the Drug Enforcement Administration's (DEA) ... |
| Date March 19, 1991 |
Report No. GGD-91-44 |
Title
-... ..-._ ..--.... ._ ._...__ __ . GA<
> I MAIL MANAGEMENT The Department of Veterans Affairs Can Further Reduce Its Postage Costs ...” ..I-~...~._ “._-I -..- ._ .._._... ..^..” ....-__._ -._-.-- -_- . ..-- (i/IO f4;(;I)-!bI-,l.l GAO United States General Accounting Office Washington, D.C. 20648 General Government Division R-242766 March 19,199l The Honorable David Pryor Chairman, Subcommit... |
| Date Nov. 1, 1990 |
Report No. RCED-91-26 |
Title
No\wIlt,t~r l!I!IO FOOD SAFETY AND QUALITY FDA Surveys Not Adequate to Demonstrate Safety of Milk SUPPlY ill llll~~lllll
142662 RELEASED
RESTRICTED--Not to be released outside the General Accounting OlTlce unless epeclf’lcally approved by the Office of Congressional Relations.
GAO/H( xn-9 1-N GA!!!0 united states
Resources, Community, Economic Development , General Accounting Office Washington, ... |
| Date April 26, 1990 |
Report No. PEMD-90-15 |
Title
P United States General Accounting Office GAO
April 1990 Report to the Chairman, Subcommittee . on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives FDA DRUG REVIEW Postapproval Risks
1976-85 Not to be released outside the BESTRICTEDGeneral Accounting Office def38 SPeCme GAO/PEMD-90-15 United States General Accounting Office Washington, D... |
| Date Oct. 27, 1989 |
Report No. PEMD-90-4FS |
Title
;, United States General Accounting Office GAO
October 1989 Fact Sheet for the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives FEDERALPRISONS
Trends in Offender Characteristics
. United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-236831 October 27,1989 The Honorable Charles B. Range1 Chairman, Select Comm... |
| Date Sept. 15, 1989 |
Report No. HRD-89-142 |
Title
U&ted States General Accounting Office “GAO
September 1989 Report to Congressional Requesters - FDA RESOURCES Comprehensive Assessment of Staffing, Facilities, and Equipment Needed g GAO/HRD-89-142 .. \! 2 ,’ ,1 Human Resources Division B-23.57 13 September 15, 1989 The Honorable Edward M. Kennedy, Chairman The Honorable Orrin G. Hatch, Ranking Minority Member Committee and Labor and Human Res... |
| Date Aug. 1, 1989 |
Report No. T-PEMD-89-5 |
Title
, United States General Accounting OilIce li GAO
For Release on Delivery Expected at 9:30 a.m. Tuesday I August 1, 1989 . Testimony lull llllllllll
139212 Drug Utilization Review Under Medicare Statement of Carl E. Wisler Director of Planning and Reporting Program Evaluation and Methodology Division Before the Subcommittee on HumanAffairs Select Committee on Aging House of Representatives GAO/T-PE... |
| Date July 13, 1989 |
Report No. PEMD-89-26BR |
Title
.,, I’( . ..b ,.1 *,.. *Jnxted States Cietiefai r.kcbuhtmg Uffice~ I ’ Briefing Report to the Chairman, Special Committee on Aging, U.S. Senate July 1989 PRESCRIPTION DRUGS HCFA’s Proposed Drug Utilization Review System Ignores Quality of Care Issues GAO/PEMD-89-26BR -- GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-235298 Jul... |
